Skip to content

Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)

Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03020277
Acronym
SMARTAUTISM
Enrollment
65
Registered
2017-01-13
Start date
2018-04-03
Completion date
2019-06-03
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorders

Brief summary

This is a prospective, longitudinal, exploratory, open study with a 6-month follow-up period to explore via a specific Smartphone© application the evolution of a child's behavior over 6 months and the (psychological and social) effects of these changes on the family.

Detailed description

This is a prospective, longitudinal, exploratory, open study with a 6-month follow-up period to assess the feasibility of using a Smartphone© application designed for parents of patients with ASD and to longitudinally collect data on the quality of life and anxiety of parents of children with ASD and the children's functional symptoms over multiple weeks under natural conditions. Population: The investigators propose to study individuals diagnosed with ASD based on National Health Authority (HAS) recommendations (on ADI-R diagnoses) from 3-16 years of age in the Pays de la Loire region. The investigators propose to include 100 families. The study is exploratory in nature; thus, randomizing patients is unnecessary. The investigators will include the first 100 families agreeing to participate in the study and meeting the inclusion criteria. All participants will be recruited from the Department of Child and Adolescent Psychiatry of University Hospital of Nantes and from the Regional Center for Autism (CRA des Pays de la Loire). Method: At the inclusion visit, parents will receive a code to download the app from the application store of their choice (depending on their Smartphone©) and sign an informed consent form. All type 1 data from the inclusion visit will be stored in an electronic database and in the Smartphone© application (during the setup process). This initial evaluation by the investigator will include the following type 1 data: * Sibling rank and marital status, * Lifestyle: rural or urban; single or multiple occupants of the chid's bedroom and housing type and surface, * Educational and teaching load and conditions (special education, inclusive education, partial or full time, etc.), and * The therapeutic management (speech therapy, psychomotor therapy, etc.). Type 2 data will be stored in the electronic database only: * Age at diagnosis, * Current drug treatments (name, starting date and dose), * Comorbidities (associated epilepsy, mental retardation and organic pathology), * Medical and psychiatric family antecedent (ATCD), * Original scores on the Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS) at the time of diagnosis, and * Scores on the French version of the Childhood Autism Rating Scale (CARS) (http://www.autisme.qc.ca) at baseline and at the end of the study.

Interventions

OTHEREcological Momentary Assessment with Smartphone© Application

Filling of the application every 3 days for 6 months by subjects (parents of patients with ASD)

Sponsors

Institut de Recherche en Santé Publique, France
CollaboratorOTHER
Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Having a child with an ASD diagnosis based on the International Classification of Diseases (ICD) 10 criteria. * Having at least one Smartphone© (iOS Apple or Android). * Signing the consent form for participation.

Exclusion criteria

* Having several children with an ASD diagnosis. * Having children living in more than two areas

Design outcomes

Primary

MeasureTime frameDescription
Filling rate of the application6 monthsThe primary outcome measure will be the filling rate (R) and the use of our application by the parents over six months. This number will be Automatically Generated by Application (AGA) Number of fillings = R 60

Secondary

MeasureTime frameDescription
child sleep disordersevery 3 days for 6 monthsSecondary outcome measure include data from the application, that will be also Automatically Generated by the Application, which is filled by the parents, predominantly using a VAS from 0 (no) to 10 (severe) to measure the following variables
child eating disordersevery 3 days for 6 monthsSecondary outcome measure include data from the application, that will be also Automatically Generated by the Application, which is filled by the parents, predominantly using a VAS from 0 (no) to 10 (severe) to measure the following variables
child general behaviorevery 3 days for 6 monthsSecondary outcome measure include data from the application, that will be also Automatically Generated by the Application, which is filled by the parents, predominantly using a Visual Analogic scale (VAS) from 0 (no) to 10 (severe) to measure the following variables
Visual Analogic scale quotation about parental self esteemevery 3 days for 6 monthsVisual Analogic scale (1 is bad to 10 is perfect ) quotation about parental self esteem by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
Visual Analogic scale quotation about parental anxietyevery 3 days for 6 monthsVisual Analogic scale (1 is bad to 10 is perfect) quotation about parental anxiety by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
Visual Analogic scale quotation about parental sleepevery 3 days for 6 monthsVisual Analogic scale (1 is bad to 10 is perfect) quotation about parental sleep by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
Visual Analogic scale quotation about parental moodevery 3 days for 6 monthsVisual Analogic scale (1 is bad to 10 is perfect) quotation about parental mood by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
Visual Analogic scale quotation about parental stressevery 3 days for 6 monthsVisual Analogic scale (1 is bad to 10 is perfect) quotation about parental stress by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
child behavior with pairsevery 3 days for 6 monthsSecondary outcome measure include data from the application, that will be also Automatically Generated by the Application, which is filled by the parents, predominantly using a VAS from 0 (no) to 10 (severe) to measure the following variables
Visual Analogic scale quotation about parental professional lifeevery 3 days for 6 monthsVisual Analogic scale (1 is unsatisfactory to 10 is satisfactory) quotation about parental professional life by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
Visual Analogic scale quotation about parental personal lifeevery 3 days for 6 monthsVisual Analogic scale (1 is unsatisfactory to 10 is satisfactory) quotation about parental personal life by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
Visual Analogic scale quotation about parental social lifeevery 3 days for 6 monthsVisual Analogic scale (1 is unsatisfactory to 10 is satisfactory) quotation about parental social life by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
Visual Analogic scale quotation about parental support and resourcesevery 3 days for 6 monthsVisual Analogic scale (1 is unsatisfactory to 10 is satisfactory) quotation about parental support and resources from third persons by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)
the duration of useevery 3 days for 6 months
the time of useevery 3 days for 6 months
rate of complete fillingevery 3 days for 6 months
Visual Analogic scale quotation about parental painevery 3 days for 6 monthsVisual Analogic scale (1 is bad to 10 is perfect) quotation about parental pain by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026